the women's health ecosystem: 29 funding events ($55M disclosed) and 23 product launches over the last 30 days.
Deals
29
-55% vs prior
Disclosed
$55M
-54% vs prior
Launches
23
New companies
0
Capital flow
29 deals in window (64 prior), $55M disclosed.
Deals
29
-55% vs prior window
Prior window
64
Disclosed volume
$55M
-54% vs prior window
Median round
$28M
Largest round
$33M
Amount disclosed
2/29
Stage mix
Undisclosed stage23 · 79%
Series B2 · 7%
Seed1 · 3%
Grant/Non-dilutive1 · 3%
Growth1 · 3%
Series A1 · 3%
Top rounds
- Circle Pharma — Series E · $93M · Series E
- Evvy — Series B · $40M · Series B
- Tiny Health — Series B · $33M · Series B
- Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device · $22M · Series A
- Teal Health — Series A · $22M · Series A
- Bird&Be — Series A · $13M · Series A
29 funding events were recorded in the last 30 days, against 64 in the prior window. 2 disclosed an amount, totalling $55M, with a median of $28M and a largest round of $33M. Stage mix: Undisclosed stage 23, Series B 2, Seed 1, Grant/Non-dilutive 1, Growth 1, Series A 1. Largest reported round: Circle Pharma — Series E.
Innovation momentum
23 launches, 0 new companies indexed.
Product launches
23
Research milestones
46
Policy events
16
New companies
0
- Clairity Bypasses Traditional Gatekeepers to Launch Direct-to-Consumer AI Breast Cancer Risk Assessment
- New Transparency Database Tracks Promotion Equity for Women Across Major U.S. Corporations
- Parkview Health Partners With Dry Days Health to Launch Bladder Care Clinic
- TelyRx Partners With SISTERLY to Integrate Nutraceuticals Into Digital Menopause Care Ecosystem
- Personalized Diagnostics Expansion Refines Long-Term Care Pathways for Hormone Receptor-Positive Breast Cancer
23 product launches, 16 policy events, and 0 newly indexed companies fall inside the window.